Boston Scientific has informed doctors of a potential problem with their Cognis or Teligen defibrillators. Some patients (15) have been delivered inappropriate shocks - a very small number of the 8,000 who might be affected.
I read about this in the morning newspaper. Further investigation led me to an AP news release dated March 27.
There is no mention of this release on Boston Scientific's own website. They have a media page of information and news releases. Their press release the previous day, March 26, gave the schedule of major announcements at the March 28-31 58th Annual Scientific Session of the American College of Cardiology, and their press release the following day, March 29, was entitled SYNTAX Analysis Finds Treatment With TAXUS® Express2™ Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease.
Their News Release page states that "Boston Scientific Corporation is not obligated to update the press releases and information contained in this section of the Site."
Boston Scientific purchased Guidant in 2006, and Cognis and Teligen are the first defibrillators launched under its own name.
Boston Scientific, one of the leaders in the medical device field, might think about the impact of allowing AP to share their news that will create anxiety, and saving their own website just for their good news.
If you don't manage your own reputation, others will manage it for you.
2 comments:
I'm not very happy with the Boston ICD's. I'm wiht my second device, but this one is much bigger than the Guidant implanted in 2002.
You would think these devices would be smaller as technology advances, not larger. Sorry to hear of your frustration. I hope you are communicating with your health care team on this, and getting some support.
Post a Comment